Cwm LLC decreased its holdings in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 33.0% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 479 shares of the health services provider’s stock after selling 236 shares during the period. Cwm LLC’s holdings in Maximus were worth $40,000 as of its most recent SEC filing.
A number of other hedge funds have also added to or reduced their stakes in MMS. Macquarie Group Ltd. bought a new stake in Maximus during the first quarter worth about $35,000. Harbor Capital Advisors Inc. acquired a new stake in shares of Maximus in the 2nd quarter valued at approximately $46,000. Fifth Third Bancorp grew its stake in shares of Maximus by 26.0% in the first quarter. Fifth Third Bancorp now owns 728 shares of the health services provider’s stock valued at $57,000 after buying an additional 150 shares in the last quarter. Harvest Fund Management Co. Ltd acquired a new position in Maximus during the first quarter worth $62,000. Finally, Captrust Financial Advisors increased its holdings in Maximus by 14.9% during the second quarter. Captrust Financial Advisors now owns 1,303 shares of the health services provider’s stock worth $81,000 after buying an additional 169 shares during the last quarter. Institutional investors own 99.30% of the company’s stock.
Insider Activity at Maximus
In other news, CEO Bruce Caswell sold 21,049 shares of the stock in a transaction dated Friday, September 29th. The shares were sold at an average price of $74.68, for a total value of $1,571,939.32. Following the completion of the transaction, the chief executive officer now owns 233,010 shares of the company’s stock, valued at $17,401,186.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Maximus news, insider Teresa Weipert sold 1,444 shares of Maximus stock in a transaction dated Friday, September 29th. The stock was sold at an average price of $74.68, for a total transaction of $107,837.92. Following the transaction, the insider now directly owns 5,493 shares of the company’s stock, valued at approximately $410,217.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Bruce Caswell sold 21,049 shares of Maximus stock in a transaction that occurred on Friday, September 29th. The stock was sold at an average price of $74.68, for a total value of $1,571,939.32. Following the completion of the transaction, the chief executive officer now directly owns 233,010 shares in the company, valued at $17,401,186.80. The disclosure for this sale can be found here. Insiders have sold 30,749 shares of company stock valued at $2,318,113 over the last three months. 1.30% of the stock is owned by insiders.
Maximus Price Performance
Maximus Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, November 30th. Investors of record on Wednesday, November 15th will be given a dividend of $0.30 per share. This is a positive change from Maximus’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend is Tuesday, November 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.58%. Maximus’s dividend payout ratio (DPR) is currently 40.00%.
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on MMS. TheStreet downgraded shares of Maximus from a “b” rating to a “c+” rating in a research report on Tuesday, August 15th. Stifel Nicolaus started coverage on Maximus in a report on Friday, August 18th. They set a “buy” rating and a $102.00 price target for the company. Finally, StockNews.com initiated coverage on Maximus in a research report on Thursday, October 5th. They set a “hold” rating on the stock.
Maximus, Inc provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
- Five stocks we like better than Maximus
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- MarketBeat Week in Review – 11/6 – 11/10
- Consumer Staples Stocks, Explained
- Data giants MongoDB and Snowflake just got upgraded
- Which Wall Street Analysts are the Most Accurate?
- Plug Power at tipping point; it’s make or break time for hydrogen
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.